GSTM1 and cirrhosis of liver: Low levels of Hb were considered to be an independent risk factor of rebleeding after EVL treatment in liver cirrhosis patients with esophageal varices (OR = 17.3491, 95% CI: 4.00–75.34, p = 0.005) (17).